Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 26-May 2015. Module: Canada Health Infoway English module (core metadata concept)
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 138331000087111 | VAQTA 50 units per milliliter suspension for injection Merck Canada Inc. (real clinical drug) | en | Fully specified name | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 96621000087116 | VAQTA 50 units per milliliter suspension for injection Merck Canada Inc. | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 96631000087119 | HA VAQTA MC | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 97671000087119 | HA VAQTA MC | fr | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway French module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| VAQTA 50 units per milliliter suspension for injection Merck Canada Inc. (real clinical drug) | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
| VAQTA 50 units per milliliter suspension for injection Merck Canada Inc. (real clinical drug) | est un(e) (attribut) | Vaccine product containing only inactivated whole Hepatitis A virus antigen (medicinal product) | true | Inferred relationship | Some | ||
| VAQTA 50 units per milliliter suspension for injection Merck Canada Inc. (real clinical drug) | a une forme pharmaceutique (attribut) | forme pharmaceutique pour usage parentéral (forme pharmaceutique) | true | Inferred relationship | Some | ||
| VAQTA 50 units per milliliter suspension for injection Merck Canada Inc. (real clinical drug) | Has supplier | Merck Canada Inc. (supplier) | true | Inferred relationship | Some | ||
| VAQTA 50 units per milliliter suspension for injection Merck Canada Inc. (real clinical drug) | est un(e) (attribut) | Product manufactured as parenteral dose form (product) | true | Inferred relationship | Some | ||
| VAQTA 50 units per milliliter suspension for injection Merck Canada Inc. (real clinical drug) | Plays role | Active immunity stimulant role (role) | true | Inferred relationship | Some | ||
| VAQTA 50 units per milliliter suspension for injection Merck Canada Inc. (real clinical drug) | Has product characteristic | Adulthood (qualifier value) | false | Inferred relationship | Some | ||
| VAQTA 50 units per milliliter suspension for injection Merck Canada Inc. (real clinical drug) | Has ingredient characteristic (attribute) | Standard dose (qualifier value) | false | Inferred relationship | Some | 1 | |
| VAQTA 50 units per milliliter suspension for injection Merck Canada Inc. (real clinical drug) | est un(e) (attribut) | Adult vaccine product containing only Hepatitis A virus regular strength antigen (medicinal product) | true | Inferred relationship | Some | ||
| VAQTA 50 units per milliliter suspension for injection Merck Canada Inc. (real clinical drug) | a pour principe actif (attribut) | Antigen of inactivated whole Hepatitis A virus (substance) | true | Inferred relationship | Some | 1 | |
| VAQTA 50 units per milliliter suspension for injection Merck Canada Inc. (real clinical drug) | Has target population | Adult population (qualifier value) | true | Inferred relationship | Some | ||
| VAQTA 50 units per milliliter suspension for injection Merck Canada Inc. (real clinical drug) | Has ingredient qualitative strength | Standard dose (qualifier value) | true | Inferred relationship | Some | 1 | |
| VAQTA 50 units per milliliter suspension for injection Merck Canada Inc. (real clinical drug) | est un(e) (attribut) | Hepatitis A virus vaccine (product) | false | Inferred relationship | Some | ||
| VAQTA 50 units per milliliter suspension for injection Merck Canada Inc. (real clinical drug) | a pour principe actif (attribut) | Hepatitis A virus vaccine (substance) | false | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Canada English language reference set (foundation metadata concept)
Administered tradename codes for vaccines reference set (foundation metadata concept)
FHIR